Concordant Promoter Methylation of Transforming Growth Factor-Beta Receptor Types I and II Occurs Early in Esophageal Squamous Cell Carcinoma

No abstract is available for this paper.

• Publication year

  2012

• Venue

  American Journal of the Medical Sciences

• Publication date

  2012-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1097/MAJ.0b013e3182253430PMID 22314103
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Aberrant CpG Island Hypermethylation of RASSF1A in Gastric Cardia Adenocarcinoma

  2009cited by this paper
• TGFβR2 aberrant methylation is a potential prognostic marker and therapeutic target in multiple myeloma

  2009cited by this paper
• Aberrant Methylation Inactivates Transforming Growth Factor β Receptor I in Head and Neck Squamous Cell Carcinoma

  2009cited by this paper
• Infrequently methylated event at sites −362 to −142 in the promoter of TGFβR1 gene in non-small cell lung cancer

  2008cited by this paper
• Concordant epigenetic silencing of transforming growth factor-beta signaling pathway genes occurs early in breast carcinogenesis.

  2007cited by this paper
• Inactivation of SMAD4 Tumor Suppressor Gene During Gastric Carcinoma Progression

  2007cited by this paper
• Histone modification in the TGFβRII gene promoter and its significance for responsiveness to HDAC inhibitor in lung cancer cell lines

  2005cited by this paper
• Insensitivity to transforming growth factor-beta results from promoter methylation of cognate receptors in human prostate cancer cells (LNCaP).

  2005cited by this paper
• Aberrant expression and mutations of TGF-beta receptor type II gene in endometrial cancer.

  2005cited by this paper
• Histone modification in the TGFbetaRII gene promoter and its significance for responsiveness to HDAC inhibitor in lung cancer cell lines.

  2005cited by this paper
• Impaired transforming growth factor β signalling in Barrett’s carcinogenesis due to frequent SMAD4 inactivation

  2005cited by this paper
• Defective Expression of Transforming Growth Factor β Receptor Type II Is Associated with CpG Methylated Promoter in Primary Non-Small Cell Lung Cancer

  2004cited by this paper
• Alterations of transforming growth factor beta receptor II, insulin growth factor receptor II genes in microsatellite unstable prostate carcinomas.

  2004cited by this paper
• Restoration of Transforming Growth Factor-β Signaling through Receptor RI Induction by Histone Deacetylase Activity Inhibition in Breast Cancer Cells*

  2004cited by this paper
• Promoter methylation of TGFβ receptor I and mutation of TGFβ receptor II are frequent events in MSI sporadic gastric carcinomas

  2003cited by this paper
• Promoter methylation of TGFbeta receptor I and mutation of TGFbeta receptor II are frequent events in MSI sporadic gastric carcinomas.

  2003cited by this paper
• Role of Smad4 (DPC4) inactivation in human cancer.

  2003cited by this paper
• Mechanisms of TGF-beta signaling from cell membrane to the nucleus.

  2003cited by this paper
• Mechanisms of TGF-β Signaling from Cell Membrane to the Nucleus

  2003cited by this paper
• Genetic and epigenetic alterations in colon cancer.

  2002cited by this paper
• Signal Transduction by the TGF-β Superfamily

  2002cited by this paper
• Decreased Smad4 expression in the transforming growth factor‐β signaling pathway during progression of esophageal squamous cell carcinoma

  2002cited by this paper
• Signal transduction by the TGF-beta superfamily.

  2002cited by this paper
• Transforming growth factor-beta receptor type I gene is frequently mutated in ovarian carcinomas.

  2001cited by this paper
• A gene hypermethylation profile of human cancer.

  2001cited by this paper
• Altered expression of TGFB receptors and mitogenic effects of TGFB in pancreatic carcinomas.

  2001cited by this paper
• TGF-beta signaling in tumor suppression and cancer progression.

  2001cited by this paper
• Molecular biology. Methylation talk between histones and DNA.

  2001cited by this paper
• Preserved Smad4 expression in the transforming growth factor beta signaling pathway is a favorable prognostic factor in patients with advanced gastric cancer.

  2001cited by this paper
• Repression of transforming growth factor-β receptor type I promoter expression by Sp1 deficiency

  2000cited by this paper
• DNA hypermethylation in tumorigenesis: epigenetics joins genetics.

  2000cited by this paper
• Raf induces TGFbeta production while blocking its apoptotic but not invasive responses: a mechanism leading to increased malignancy in epithelial cells.

  2000cited by this paper
• No SMAD4 hypermethylation in colorectal cancer

  2000cited by this paper
• Transcriptional repression of the transforming growth factor-β type I receptor gene by DNA methylation results in the development of TGF-β resistance in human gastric cancer

  1999cited by this paper
• Loss of transforming growth factor-beta type II receptor gene expression in primary human esophageal cancer.

  1996cited by this paper
• Infrequent DPC4 gene mutation in esophageal cancer, gastric cancer and ulcerative colitis-associated neoplasms.

  1996cited by this paper
• DPC4, A Candidate Tumor Suppressor Gene at Human Chromosome 18q21.1

  1996cited by this paper
• A transforming growth factor beta receptor type II gene mutation common in colon and gastric but rare in endometrial cancers with microsatellite instability.

  1995cited by this paper

• CircFAM120B Blocks the Development of Colorectal Cancer by Activating TGF-Beta Receptor II Expression via Targeting miR-645

  2021cites this paper
• Tumor Niche Disruption and Metastasis: The Role of Epithelial-Mesenchymal Transition (EMT)

  2019cites this paper
• Molecular and Cell Biology of Cancer

  2019cites this paper
• Global methylation profiles in buccal cells of long-term smokers and moist snuff consumers

  2018cites this paper
• MicroRNA‐155 promotes gastric cancer growth and invasion by negatively regulating transforming growth factor‐β receptor 2

  2018cites this paper
• DNA Tumor Virus Regulation of Host DNA Methylation and Its Implications for Immune Evasion and Oncogenesis

  2018cites this paper
• Expression and clinical relations of protein tyrosine phosphatase receptor type S in esophageal squamous cell carcinoma.

  2018cites this paper
• Synergistic effect of siRNA‐mediated silencing of TGF‐β R1 and TGF‐β R2 genes on the proliferation and apoptosis of penile urethral epithelial cells in hypospadiac male rats

  2018cites this paper
• Aberrant methylation of DACT1 and DACT2 are associated with tumor progression and poor prognosis in esophageal squamous cell carcinoma

  2017cites this paper
• RG108 induces the apoptosis of endometrial cancer Ishikawa cell lines by inhibiting the expression of DNMT3B and demethylation of HMLH1.

  2017cites this paper
• Targeting TGF-β Signaling for Therapeutic Gain.

  2017cites this paper
• An androgen-regulated miR-2909 modulates TGFβ signalling through AR/miR-2909 axis in prostate cancer.

  2017cites this paper
• Methylation and expression of PTPN22 in esophageal squamous cell carcinoma

  2016cites this paper
• Downregulation of the TGFβ Pseudoreceptor BAMBI in Non-Small Cell Lung Cancer Enhances TGFβ Signaling and Invasion.

  2016cites this paper
• miR-135b Promotes Cancer Progression by Targeting Transforming Growth Factor Beta Receptor II (TGFBR2) in Colorectal Cancer

  2015cites this paper
• Aberrant methylation and decreased expression of the TGF‐β/Smad target gene FBXO32 in esophageal squamous cell carcinoma

  2014influential citation
• Concerted loss of TGFβ-mediated proliferation control and E-cadherin disrupts epithelial homeostasis and causes oral squamous cell carcinoma.

  2014cites this paper
• Cellular responses to TGFβ and TGFβ receptor expression in human colonic epithelial cells require CaSR expression and function.

  2013cites this paper
• Decreased expression and aberrant methylation of Gadd45G is associated with tumor progression and poor prognosis in esophageal squamous cell carcinoma

  2013cites this paper
• Cancer Development, Progression, and Therapy: An Epigenetic Overview

  2013cites this paper